The challenges of handling deferasirox in sickle cell disease patients older than 40 years-Reference-Cited by-同舟云学术

The challenges of handling deferasirox in sickle cell disease patients older than 40 years

Published:2019-01-01 Issue:1 Volume:24 Page:596-600
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Ribeiro Lorena Bedotti¹,Soares Eliane Alves¹,Costa Fernando Ferreira¹,Gilli Simone Cristina Olenscki¹,Olalla Saad Sara Teresinha¹^ORCID,Benites Bruno Deltreggia¹^ORCID

Affiliation:

1. Hematology and Transfusion Medicine Center, University of Campinas, Brazil

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2019.1657667

Reference18 articles.

1. Management of Patients with Sickle Cell Disease Using Transfusion Therapy

2. The Pathophysiology of Transfusional Iron Overload

3. How we manage iron overload in sickle cell patients

4. Approaches to Transfusion Therapy and Iron Overload in Patients with Sickle Cell Disease: Results of an International Survey

5. Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-derived extracellular vesicles represent a promising endogenous iron-chelating therapy for iron overload and cardiac injury in myocardial infarction;Journal of Nanobiotechnology;2024-08-31

2. Identification of Isoliensinine as a Ferroptosis Suppressor with Iron-Chelating Activity;Journal of Natural Products;2024-08-19

3. A critical review of therapeutic interventions in sickle cell disease: Progress and challenges;Archiv der Pharmazie;2024-07-19

4. Compare the Efficacy and Safety of Deferoxamine, Deferasirox, and Deferiprone in Patients With Sickle Cell Disease or Transfusion-Dependent Anemia: A Network Meta-Analysis of Randomized Control Trials;Cureus;2024-02-05

5. Ferroptosis as an emerging target in sickle cell disease;Current Research in Toxicology;2024